stoxline Quote Chart Rank Option Currency Glossary
  
TC Biopharm (Holdings) Plc (TCBP)
1.35  0.02 (1.5%)    04-17 16:00
Open: 1.38
High: 1.38
Volume: 67,039
  
Pre. Close: 1.33
Low: 1.3
Market Cap: 1(M)
Technical analysis
2024-04-17 4:49:56 PM
Short term     
Mid term     
Targets 6-month :  2.88 1-year :  3.81
Resists First :  2.47 Second :  3.26
Pivot price 1.53
Supports First :  1.17 Second :  0.98
MAs MA(5) :  1.46 MA(20) :  1.53
MA(100) :  2.52 MA(250) :  70.94
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  7.1 D(3) :  12
RSI RSI(14): 43.6
52-week High :  320 Low :  0.85
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TCBP ] has closed above bottom band by 30.9%. Bollinger Bands are 91.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 92 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.38 - 1.39 1.39 - 1.39
Low: 1.29 - 1.29 1.29 - 1.3
Close: 1.34 - 1.35 1.35 - 1.36
Company Description

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Headline News

Thu, 04 Apr 2024
TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics - Seeking Alpha

Tue, 02 Apr 2024
TCBP Increasing Treatment Capacity with Expanded Manufacturing Process - Yahoo Finance

Tue, 19 Mar 2024
TCBP Adjourns General Meeting Until a Later Date - Yahoo Finance

Mon, 11 Mar 2024
TC BioPharm Ltd (TCBP) Stock Gains 115.87% This Week: Is It a Good Pick? - InvestorsObserver

Wed, 06 Mar 2024
Should You Add TC BioPharm Ltd (TCBP) Stock to Your Portfolio Wednesday? - InvestorsObserver

Fri, 01 Mar 2024
Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show" - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 3 (M)
Shares Float 64 (M)
Held by Insiders 0 (%)
Held by Institutions 2.4 (%)
Shares Short 204 (K)
Shares Short P.Month 197 (K)
Stock Financials
EPS -24.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.6
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -88.1 %
Return on Equity (ttm) -391.7 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -4.26
Qtrly Earnings Growth 0 %
Operating Cash Flow -11 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -0.06
PEG Ratio 0
Price to Book value 0.51
Price to Sales 0
Price to Cash Flow -0.41
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android